What to Avoid When Taking Emgality (Galcanezumab)
Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 31st, 2026.
Published on July 27th, 2026. Updated on July 31st, 2026.
Key takeaways
Combining galcanezumab with other CGRP-pathway drugs like erenumab or rimegepant raises safety concerns and is generally avoided without physician guidance.
Lifestyle triggers such as alcohol, poor sleep, and skipped meals can work against galcanezumab's preventive effect, even when the medication is taken correctly.
Proper injection technique and site rotation are essential for a biologic medication; errors here can directly reduce how well the drug works.
Pregnancy and breastfeeding decisions require early, proactive conversations with your prescriber because human safety data for galcanezumab remain limited.
Knowing when to stop and contact a doctor, such as during signs of a serious allergic reaction or cardiovascular changes, is just as important as knowing how to take the medication.
Known Drug Interactions to Watch For
Galcanezumab has a relatively limited formal drug interaction list compared to many oral migraine medications, but that does not mean it is entirely free of concerns. The most important category to watch is other CGRP-pathway agents. Combining galcanezumab with medications like erenumab, fremanezumab, rimegepant, or ubrogepant is generally avoided because the cumulative effect on the CGRP system is not well studied and the benefit of stacking these agents has not been established.
Using triptans alongside galcanezumab is not strictly contraindicated, but it does require physician oversight. Both types of medication act on migraine pathways, so your doctor needs the full picture of what you are taking. Similarly, frequent reliance on acute pain relievers, whether NSAIDs, opioids, or triptans, can lead to medication overuse headache. This pattern may actually blunt the preventive benefit that galcanezumab is designed to provide, creating a cycle that is hard to break.
Medication Type |
Can It Be Used Alongside Emgality? |
Key Caution |
|---|---|---|
NSAIDs (ibuprofen, naproxen) |
Yes, occasionally |
Frequent use may cause medication overuse headache |
Triptans (sumatriptan, rizatriptan) |
Yes, with physician oversight |
Overuse risk; both act on migraine pathways |
Other CGRP monoclonal antibodies (erenumab, fremanezumab) |
Generally avoided |
Additive CGRP suppression; safety data lacking |
Gepants (rimegepant, ubrogepant) |
Use with caution |
Combined CGRP pathway effects not well established |
Oral preventives (topiramate, propranolol) |
Often yes, under supervision |
Monitor for tolerability and overlapping effects |
Injection Site Mistakes That Undermine the Drug
Because galcanezumab is a biologic delivered by subcutaneous injection, technique matters more than it would with a pill. Injecting into skin that is red, bruised, tender, or affected by active psoriasis lesions can increase local irritation and lead to irregular absorption of the medication.
After administering the dose, rubbing the injection site is a common but counterproductive habit. It can worsen local reactions like redness and swelling. Equally important is rotating injection sites with each dose. Repeatedly using the same spot can cause small lumps under the skin and may affect how consistently the drug is absorbed, which in turn affects how reliably it works over time. Approved sites generally include the abdomen, thigh, and upper arm.
Lifestyle Factors That Can Work Against Treatment
Galcanezumab cannot fully compensate for lifestyle patterns that are known to provoke migraines. Alcohol is one of the most commonly reported personal triggers, and heavy or frequent drinking makes it genuinely difficult to evaluate whether the medication is helping. If attacks continue during treatment, your prescriber needs accurate information to make that judgment.
Sleep is another major factor. Irregular sleep schedules and chronic sleep deprivation are well-documented migraine triggers that can override the drug's preventive effect. Establishing consistent sleep habits during treatment gives galcanezumab the best chance to demonstrate its benefit. Skipping meals or following extreme diets can have a similar sabotaging effect. Stable blood sugar and regular nutrition help maintain an environment where preventive therapy can actually work.
Doctronic, now serving more than 22 million AI consultations, often fields questions from patients who are doing everything right medically but unknowingly undermining their treatment through daily habits. Small adjustments in routine can make a meaningful difference in outcomes.
What to Avoid During Pregnancy and Breastfeeding
CGRP plays a known role in regulating blood vessel tone during pregnancy, which raises theoretical concerns about blocking this pathway during gestation. There are currently no adequate human studies on galcanezumab use in pregnancy, so the risk profile is uncertain.
Patients who are planning to become pregnant should raise this topic with their prescriber well in advance, not after a positive pregnancy test. Timing any discontinuation carefully, with medical guidance, is important. The same caution applies to breastfeeding. Limited data exist on whether galcanezumab passes into breast milk or affects a nursing infant. This is a decision that requires a candid risk-benefit conversation with a clinician who knows your full health history.
Storage and Handling Errors That Affect Potency
As a biologic medication, galcanezumab is more sensitive to storage conditions than most pills or small-molecule drugs. Freezing the autoinjector is one of the most common and consequential mistakes. Even a single freeze-thaw cycle can degrade the protein structure of the medication, rendering the dose ineffective without any visible sign that something is wrong.
Heat exposure is equally damaging. Leaving the pen in a hot car or in direct sunlight, particularly at temperatures above 77 degrees Fahrenheit for extended periods, compromises stability. Room temperature storage for up to 30 days is acceptable, but sustained heat is not. If the pen has been dropped and shows visible cracks or damage, or if it has passed its expiration date, it should not be used. Contact your pharmacist for guidance on replacement if you are unsure about a pen's condition.
Recognizing When to Pause or Stop Treatment
Knowing when to hold the medication is just as important as knowing how to take it correctly. Serious hypersensitivity reactions, including rash, facial swelling, or difficulty breathing, require immediate discontinuation and emergency evaluation. These reactions are not common, but they are serious and should not be managed with a wait-and-see approach.
Because CGRP plays a role in vasodilation, patients who develop new cardiovascular symptoms such as chest tightness or meaningful changes in blood pressure should not continue dosing without speaking to their physician first. Galcanezumab is first authorized to practice medicine in states including Utah, and providers on platforms like Doctronic can help patients navigate exactly these kinds of mid-treatment questions quickly.
Finally, if you miss a scheduled dose, call your prescriber rather than simply doubling up at your next injection. Double-dosing is not recommended and does not improve outcomes. Your provider can advise on the best way to get back on schedule safely.
Frequently Asked Questions
Yes, occasional use of NSAIDs like ibuprofen alongside galcanezumab is generally permitted. However, frequent or daily use of any acute pain reliever, including NSAIDs, triptans, and opioids, can cause medication overuse headache. This pattern may blunt the preventive benefit of galcanezumab over time, so careful use is important.
Alcohol does not directly interact with galcanezumab chemically, but it is a well-documented personal migraine trigger for many people. Heavy or frequent drinking can provoke attacks and make it difficult to assess whether the medication is providing its full preventive benefit, especially during the early months of treatment.
Combining galcanezumab with standard preventive medications like topiramate or propranolol is sometimes done under physician supervision. However, using it alongside other CGRP-pathway agents such as erenumab, fremanezumab, or gepants raises specific safety questions and is generally avoided. Always review any combination with your prescriber first.
Freezing degrades the biologic protein in galcanezumab and can render the dose ineffective. If an autoinjector has been frozen, it should not be used. Contact your pharmacist or prescriber for guidance on replacement. Emgality should be stored in the refrigerator between 36 and 46 degrees Fahrenheit, never in the freezer.
Galcanezumab does not cause physical dependence, so stopping it does not produce withdrawal symptoms in the traditional sense. However, migraine frequency may gradually return after discontinuation. Rather than stopping on your own, it is best to discuss timing and tapering considerations with your prescriber to plan the transition thoughtfully.
The Bottom Line
Getting the most from galcanezumab means more than just remembering your monthly injection. Avoiding the specific pitfalls covered here, including risky drug combinations, injection and storage mistakes, lifestyle triggers, and knowing when to pause treatment, is what separates patients who see full preventive benefit from those who do not. If you have questions before or between appointments, Doctronic offers free AI consultations and $39 video visits available 24/7, with a track record of 99.2% treatment plan alignment with board-certified physicians. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get pain relief advice
Chat Now